Literature DB >> 1754055

Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system.

K Unsicker1, K C Flanders, D S Cissel, R Lafyatis, M B Sporn.   

Abstract

The distribution of transforming growth factor-beta isoforms 1, 2 and 3 and transforming growth factor-beta 2 and 3 mRNAs in adult rat central and peripheral nervous system was examined using Northern blotting and isoform specific antibodies for immunocytochemistry. Transforming growth factor-beta 2 and 3 mRNA were present in all brain areas including cerebral cortex, hippocampus, striatum, cerebellum and brainstem. In sciatic nerve, transforming growth factor-beta 3 mRNA was highly expressed, but transforming growth factor-beta 2 mRNA was not detectable. Transforming growth factor-beta 1-like immunoreactivity was confined to meninges and choroid plexus in the brain and connective tissue in peripheral ganglia and nerves. Transforming growth factor-beta 2 and 3 immunoreactivity entirely overlapped and, in general, were found in large multipolar neurons. Highest densities of immunoreactive neuronal perikarya were present in spinal cord and brainstem motor nuclei, hypothalamus, amygdaloid complex, hippocampus and cerebral cortical layers II, III and V. Most thalamic nuclei, superior colliculi, periaqueductal gray and striatum were almost devoid of transforming growth factor-beta 2- and 3-immunoreactive neurons. Fibrous astrocytes in white matter areas were intensely immunostained. Most dorsal root ganglionic neurons, their satellite cells and Schwann cells in peripheral nerves were also labeled. Transforming growth factor-beta 2- and 3-immunoreactive neurons were localized in brain regions that have been shown to contain neurons synthesizing and/or storing basic fibroblast growth factor suggesting possible opposing or synergistic effects of these peptide growth factors. However, the precise functions of local synthesis and storage of the transforming growth factor-beta isoforms in the nervous system are as yet unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1754055     DOI: 10.1016/0306-4522(91)90082-y

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  48 in total

1.  Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration.

Authors:  Jian Luo; Amy H Lin; Eliezer Masliah; Tony Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

2.  TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.

Authors:  Yang Liu; Qing Wang; B K Kleinschmidt-DeMasters; Alex Franzusoff; Ka-yun Ng; Kevin O Lillehei
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

3.  Neurons promote macrophage proliferation by producing transforming growth factor-beta2.

Authors:  A Dobbertin; P Schmid; M Gelman; J Glowinski; M Mallat
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 4.  Cytokines, inflammation, and pain.

Authors:  Jun-Ming Zhang; Jianxiong An
Journal:  Int Anesthesiol Clin       Date:  2007

5.  Ventral mesencephalon astrocytes are more efficient than those of other regions in inducing dopaminergic neurons through higher expression level of TGF-beta3.

Authors:  Kairong Li; Bing Xue; Yue Wang; Xuan Wang; Haomin Wang; Xiaomin Wang
Journal:  J Mol Neurosci       Date:  2008-11-04       Impact factor: 3.444

6.  Chronically increased transforming growth factor-beta1 strongly inhibits hippocampal neurogenesis in aged mice.

Authors:  Marion S Buckwalter; Makiko Yamane; Bronwen S Coleman; Brandi K Ormerod; Jocelyn T Chin; Theo Palmer; Tony Wyss-Coray
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 7.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

8.  Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons.

Authors:  K Krieglstein; P Henheik; L Farkas; J Jaszai; D Galter; K Krohn; K Unsicker
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-β1 in the CNS.

Authors:  Thomas Koeglsperger; Shaomin Li; Christian Brenneis; Jessica L Saulnier; Lior Mayo; Yijun Carrier; Dennis J Selkoe; Howard L Weiner
Journal:  Glia       Date:  2013-03-28       Impact factor: 7.452

10.  Endogenous TGFβ1 Plays a Crucial Role in Functional Recovery After Traumatic Brain Injury Associated with Smad3 Signal in Rats.

Authors:  Xu-Yang Wang; Ying-Chun Ba; Liu-Lin Xiong; Xiao-Li Li; Yu Zou; Ye-Chun Zhu; Xin-Fu Zhou; Ting-Hua Wang; Fang Wang; Heng-Li Tian; Jin-Tao Li
Journal:  Neurochem Res       Date:  2015-08-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.